Pancreatic Cancer

We combine evidence-based medicine with compassionate, personalized care to diagnose and treat people with pancreatic cancer. Our team of specialists is at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

At our Pancreatic Cancer Center, we create an individualized treatment plan for you, drawing on our expertise in endoscopic and surgical treatments as well as medical therapies.

Meet Our Doctors

Our Approach to Treating Pancreatic Cancer

Our Approach to Pancreatic Cancer Treatment

Diagnosis

Surgery

Chemotherapy & Targeted Drugs

Radiation Therapy

Clinical Trials and Research Studies

Phase 2

A phase II study of nivolumab cabiralizumab and stereotactic body radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer

Learn More

Phase 2

CA025-006 A Phase 2 Study of Cabiralizumab (BMS-986227 FPA008) Administered in Combination with Nivolumab (BMS-936558) with and without Chemotherapy in Patients with Advanced Pancreatic Cancer relating to BMS Compounds: BMS-986227 FPA008

Learn More

Phase 1

Phase 1b Open-label Study of MK-7162 in Combination with Pembrolizumab (MK-3475) +/- other therapies in Participants with Advanced Solid Tumors

Learn More

Phase 2

Perioperative Therapy for Resectable Pancreatic Adenocarcinoma and Borderline Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Learn More

View All Related Clinical Trials (5)